About GinHwa
GinHwa is a publicly listed company. GinHwa offers products and services including Health Supplements and Raw Material Development. Its focus areas include Food and Agriculture and Food Processing. Its legal entity in India is η²Ύθ―ηι«θ‘δ»½ζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Manufacturer of nutritional supplement products and contract manufacturer. It offers a full range of dosage forms, including softgels, tablets, capsules, liquids, powders, and more. The company provides comprehensive services encompassing formulation development, manufacturing, and quality control, adhering to stringent international standards. Its expertise extends to custom formulation design to meet specific client needs. A focus on advanced extraction techniques and innovative manufacturing processes ensures high-quality, consistent products.
- Stage Public
- SectorsConsumer
- Website gin-hwa.com
- Social YouTube
- Legal Name Gin Hwa Biotech, Inc.
- Annual Revenue$538.65 M23.8as on Dec 31, 2025
- Net Profit$75.33 M12.85as on Dec 31, 2025
- EBITDA$130.36 M16.59as on Dec 31, 2025
Associated legal entities of GinHwa
GinHwa operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of GinHwa
GinHwa offers a comprehensive portfolio of products and services, including Health Supplements and Raw Material Development.
Health supplements in forms such as powders and capsules are manufactured by 精華生醫 for global distribution.
Specialized ingredients and formulas are developed by 精華生醫 to support health product creation.
Apps and channels of GinHwa
its YouTube channel 精華生醫 has 11 subscribers.
IPO & Listings of GinHwa
GinHwa is a publicly listed company on the TPEX with ticker symbol 7806 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Dec 2024
- Listed onTT: 7806
- Listed entityGin Hwa Biotech, Inc.
- Exchange sectorHealth technology
- ISINTW0007806002
- Share price57.00 TWD (-1.72% on the day) · 2026-10-14
- Market capitalisation1,696,674,015.00 TWD
- Dividend yield1.56%
- Volume (last session)102,332
Financials of GinHwa
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 538.6M TWD | 75.3M TWD | 130.4M TWD |
| 2024 | 435.1M TWD | 66.8M TWD | 111.8M TWD |
| 2023 | 403.6M TWD | 82.4M TWD | 127.7M TWD |
| 2022 | 139.4M TWD | 29.6M TWD | 58.0M TWD |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for GinHwa
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ginhwa
Complete news archive for GinHwa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GinHwa
Manufacturer of nutritional supplement products and contract manufacturer. It offers a full range of dosage forms, including softgels, tablets, capsules, liquids, powders, and more. The company provides comprehensive services encompassing formulation development, manufacturing, and quality control, adhering to stringent international standards. Its expertise extends to custom formulation design to meet specific client needs. A focus on advanced extraction techniques and innovative manufacturing processes ensures high-quality, consistent products.
GinHwa offers Health Supplements and Raw Material Development.
Yes, GinHwa is publicly traded on TPEX under the ticker symbol 7806.
GinHwa operates through ,.